Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	39.26	43.05	65.47	112.35	4.21	3.22
Short-Term Investments	10	24.69	17.38	-	-	-
Cash & Short-Term Investments	49.26	67.74	82.85	112.35	4.21	3.22
Cash Growth	-43.62%	-18.24%	-26.26%	2566.65%	30.96%	-85.15%
Accounts Receivable	6.65	16.12	7.19	1.42	2.44	1.68
Other Receivables	2.3	1.26	1.11	0.11	0.14	0.18
Receivables	8.95	17.38	8.3	1.53	2.58	1.87
Prepaid Expenses	2.69	1.82	1.69	0.89	0.66	0.48
Restricted Cash	-	-	-	-	0.11	0.34
Other Current Assets	-	-	-	0.29	0.83	1.07
Total Current Assets	60.89	86.94	92.83	115.06	8.38	6.97
Property, Plant & Equipment	1.59	1.53	1.78	2.03	2.39	3.01
Long-Term Investments	-	-	20	15.42	-	-
Goodwill	4.7	4.7	-	-	-	-
Other Intangible Assets	66.15	69.23	-	-	-	-
Long-Term Accounts Receivable	-	-	-	-	0.4	0.4
Other Long-Term Assets	11.07	9.94	0.72	0.44	0.04	0.13
Total Assets	144.41	172.33	115.34	132.94	11.21	10.51
Accounts Payable	20.45	13.99	3.61	0.52	1.17	1.14
Accrued Expenses	6.77	18.97	7.21	2.52	5.47	3.77
Short-Term Debt	-	37.7	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	0.39	-
Current Portion of Leases	0.6	0.54	0.49	0.37	0.5	0.52
Other Current Liabilities	2.63	2.52	0.71	0.82	-	-
Total Current Liabilities	30.45	73.72	12.02	4.23	7.54	5.43
Long-Term Debt	58.33	5.07	12.8	-	68.05	77.34
Long-Term Leases	0.54	0.46	0.84	1.24	1.61	2.07
Other Long-Term Liabilities	22.61	31.22	14.55	0.36	0.43	0.12
Total Liabilities	111.93	110.46	40.22	5.82	77.62	84.96
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	479.36	472.66	436.27	396.96	192.06	171.26
Retained Earnings	-436.33	-399.78	-353.73	-267.03	-258.47	-245.71
Treasury Stock	-10.98	-10.98	-7.54	-2.81	-	-
Comprehensive Income & Other	0.42	-0.04	0.11	-	-	-
Total Common Equity	32.48	61.86	75.12	127.12	-66.41	-74.46
Shareholders' Equity	32.48	61.86	75.12	127.12	-66.41	-74.46
Total Liabilities & Equity	144.41	172.33	115.34	132.94	11.21	10.51
Total Debt	59.47	43.77	14.13	1.61	70.55	79.93
Net Cash (Debt)	-10.21	23.97	68.72	110.74	-66.33	-76.72
Net Cash Growth	-	-65.12%	-37.94%	-	-	-
Net Cash Per Share	-0.26	0.68	1.99	3.72	-16.66	-41.39
Filing Date Shares Outstanding	52.62	41.85	34.54	34.42	28.38	3.17
Total Common Shares Outstanding	41.99	41.53	34.54	35.01	4.54	2.27
Working Capital	30.44	13.22	80.81	110.83	0.85	1.54
Book Value Per Share	0.77	1.49	2.17	3.63	-14.64	-32.77
Tangible Book Value	-38.38	-12.06	75.12	127.12	-66.41	-74.46
Tangible Book Value Per Share	-0.91	-0.29	2.17	3.63	-14.64	-32.77
Machinery	-	1.51	1.28	1.05	1.01	1.06
Leasehold Improvements	-	0.71	0.71	0.72	0.72	0.96

Source: S&P Capital IQ. Standard template. Financial Sources.